№ lp_1_2_17730
File format: docx Character count: 3592 File size: 73 KB
Note: Year
Subject: Thrombophilia testing, Lupus Anticoagulant screening
Document Type: Medical form
Target Audience: Medical team, requesting clinicians
Context: Medical form for requesting thrombophilia and lupus anticoagulant testing, including details for genetic testing and sample collection.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
PQS Oral Anticoagulant Safety Audit 2021/22 - Data Collection Form
Year: 2021/22
Region / City: Not specified
Subject: Anticoagulant Safety
Document Type: Data Collection Form
Organization: Not specified
Author: Not specified
Target Audience: Healthcare professionals involved in patient care and anticoagulant management
Period of Validity: Not specified
Approval Date: Not specified
Modification Date: Not specified
In Vitro Anticoagulant Effect of Aqueous Garlic (Allium sativum) Extract on Human Plasma Coagulation
Year: 2024–2025
Institution: Department of Hematology, Faculty of Medical Laboratory Sciences
Type of Document: Experimental study
Subject: Anticoagulant effect of garlic extract on human plasma
Methodology: In vitro, PT and APTT measurement
Sample Size: 15 normal human blood samples
Intervention: Aqueous extract of Allium sativum at concentrations 25%, 50%, and 100%
Key Findings: Prolongation of PT and APTT with increasing extract concentration
Keywords: Garlic, Allium sativum, Herbal medicine, Anticoagulant, PT, APTT
Publication Status: Abstract and full study data included
HopeHealth Launches Phase 3 Clinical Trial Site to Advance Lupus Research with Support from Bristol Myers Squibb, August 29, 2025
Date: August 29, 2025
Location: Florence, South Carolina
Organization: HopeHealth
Sponsor: Bristol Myers Squibb
Type of document: Press release
Subject: Launch of Phase 3 clinical trial site for systemic lupus erythematosus (SLE)
Clinical trial phase: Phase 3
Investigational medication: Deucravacitinib
Principal investigator: Supen Patel
Chief medical officer: Edward Behling
Corporate representative: Andrew Whitehead
Disease focus: Systemic lupus erythematosus (SLE)
Geographic focus: Rural South Carolina, Pee Dee region
Participating population: Patients with systemic lupus erythematosus
Issuing contact: Monica Hanna, [email protected]
Note: , (843) 432-2959
Supplementary Table 1: Full Ovid MEDLINE Search Strategy for Cutaneous Lupus Erythematosus and Plant-Derived Interventions
Document Type: Supplementary table
Database: Ovid MEDLINE
Subject: Cutaneous Lupus Erythematosus and plant-derived or antimalarial interventions
Content Type: Search strategy
Medical Subject Headings (MeSH): Lupus Erythematosus, Cutaneous; Plants; Plant Structures; Fungi; Bacteria; Herbal Medicine; Antimalarials; Artemisinins; Chloroquine; Quinidine; Quinine
Keywords Included: botanical terms, herbal medicine, traditional Chinese medicine, Janus kinase inhibitors, antimalarial agents, specific plant genera and compounds
Search Fields: Title and abstract (ti,ab)
Boolean Logic: Combination of controlled vocabulary and keyword terms using AND/OR operators
Purpose: Identification of relevant biomedical literature
Systemic Lupus Erythematosus: From Mouse Models to Human Disease and Treatment, September 2–3, 2010, National Institutes of Health, Bethesda, Maryland
Year: 2010
Location: Bethesda, Maryland, USA
Subject: Systemic Lupus Erythematosus, Autoimmune Disease, Translational Research
Document type: Conference Report
Organizers: National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Allergy and Infectious Diseases, Office of Research on Women’s Health, NIH
Collaborators: Lupus Foundation of America, Inc.
Authors/Speakers: Dr. Betty Diamond, Dr. Timothy Behrens, Dr. Howard Young, Dr. Silvia Bolland, Dr. Juan Rivera, Dr. Joe Craft, Dr. Mary Crow, Dr. David Close, Dr. Virginia Pascual, Dr. Mariana Kaplan
Conference dates: September 2–3, 2010
Topics covered: Interferon and innate responses, autoantibodies, lymphocyte activation, clinical challenges, genetic analysis of lupus, translational research from mouse models to human disease
Target audience: Basic and clinical scientists, researchers in academia, industry, and government
Type of sessions: Lectures, panel discussions, and research presentations
Research focus: Mechanisms of lupus pathogenesis, type I interferon signature, B cell and T cell involvement, translational insights from mouse models, therapeutic development, clinical trials
Summary: Conference proceedings detailing presentations and discussions on systemic lupus erythematosus, including translational studies from mouse models to human disease, mechanisms of immune dysregulation, and emerging therapies.
Systemic Lupus Erythematosus: Endothelial Microparticles and Disease Activity in Women
Year: 2013–2016
Region / City: Belo Horizonte, Brazil
Topic: Systemic Lupus Erythematosus, Endothelial Microparticles
Document Type: Research Article
Institution: Federal University of Minas Gerais, Santa Casa Hospital
Authors: Walter B. Cicarini, Karine S. Ferreira, Cristina M.G. Loures, Renato V. Consoli, Cláudia L.S. Neiva, Paulo M. Pádua, Fernanda F.C. Nunes, Luan C.V. Alves, Edna A. Reis, Vicente P.C.P Toledo, Bashir A. Lwaleed, Maria G. Carvalho
Funding: CNPq, CAPES, FAPEMIG
Study Design: Cross-sectional
Participants: 90 women, including healthy volunteers and SLE patients with low and moderate/high disease activity
Methods: Blood collection, ultracentrifugation, flow cytometry
Outcome Measures: Endothelial microparticles levels, correlation with SLEDAI-2K Score and age
Ethical Approval: Research Ethics Committee of the Federal University of Minas Gerais, Reference 01928412.8.0000.5149
Inclusion Criteria: Women aged-matched, SLE diagnosis per ACR criteria 1997
Exclusion Criteria: Other autoimmune diseases, anticoagulant use, pregnancy, immunosuppressive diseases
Treatment: Azathioprine, Prednisone, Hydroxychloroquine
Corresponding Author: Bashir A. Lwaleed, University of Southampton, UK
Topics: Thrombophilia Anticoagulant Lupus